Physician profile
Anjali Kumar
NPI 1386892966
$1,228.46
in general payments reported to CMS, 2019-2025
10 companies · $750 in 2025
The $750 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.71 · 2020: $97.28 · 2022: $63.03 · 2023: $33.52 · 2024: $271 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $567.60 | 2020-2025 | Cardiomems, Perclose Proglide |
| Abiomed | $217.76 | 2025 | |
| Medtronic, INC. | $139.07 | 2024 | Corevalve Evolut R |
| Astrazeneca Pharmaceuticals Lp | $116.15 | 2025 | Saphnelo |
| Angiodynamics, INC. | $50.00 | 2024 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $46.54 | 2019-2023 | Gardasil 9, Vaxelis, M-M-R II |
| Urovant Sciences INC | $44.24 | 2022 | |
| Aurinia Pharma U.S., INC. | $18.48 | 2023 | Lupkynis |
| Boston Scientific Corporation | $15.03 | 2024 | |
| Pfizer INC. | $13.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.